West Pharmaceutical Services, Inc. (BMV:WST)
Mexico · Delayed Price · Currency is MXN 4,435.00
0.00 (0.00%)
At close: Sep 23, 2025
BMV:WST Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| 2,960 | 2,893 | 2,950 | 2,887 | 2,832 | 2,147 | Upgrade | |
Revenue Growth (YoY) | 2.90% | -1.92% | 2.18% | 1.95% | 31.89% | 16.69% | Upgrade |
Cost of Revenue | 1,916 | 1,895 | 1,821 | 1,751 | 1,656 | 1,379 | Upgrade |
Gross Profit | 1,044 | 998.5 | 1,129 | 1,136 | 1,176 | 767.8 | Upgrade |
Selling, General & Admin | 352.7 | 338.5 | 353.4 | 316.9 | 362.8 | 302 | Upgrade |
Research & Development | 69.4 | 69.1 | 68.4 | 58.5 | 52.8 | 46.9 | Upgrade |
Other Operating Expenses | 40.4 | 21 | 31.4 | 26.8 | 7.9 | 12 | Upgrade |
Operating Income | 581.6 | 569.9 | 676 | 734 | 752.3 | 406.9 | Upgrade |
Interest Income | 17.1 | 19.6 | 28 | 5.1 | 1 | 1.4 | Upgrade |
Interest Expense | - | -3 | -9 | -7.9 | -8.2 | -8.2 | Upgrade |
Other Non-Operating Income (Expense) | -1.4 | -1 | 3 | -51.3 | 3.8 | 1.2 | Upgrade |
Total Non-Operating Income (Expense) | 15.7 | 15.6 | 22 | -54.1 | -3.4 | -5.6 | Upgrade |
Pretax Income | 597.3 | 585.5 | 698 | 679.9 | 748.9 | 401.3 | Upgrade |
Provision for Income Taxes | 123.5 | 107.5 | 122.3 | 114.7 | 107.2 | 72.5 | Upgrade |
Net Income | 488.1 | 492.7 | 593.4 | 585.9 | 661.8 | 346.2 | Upgrade |
Minority Interest in Earnings | -14.3 | -14.7 | -17.7 | -20.7 | -20.1 | -17.4 | Upgrade |
Net Income to Common | 488.1 | 492.7 | 593.4 | 585.9 | 661.8 | 346.2 | Upgrade |
Net Income Growth | -8.27% | -16.97% | 1.28% | -11.47% | 91.16% | 43.23% | Upgrade |
Shares Outstanding (Basic) | 73 | 73 | 74 | 74 | 74 | 74 | Upgrade |
Shares Outstanding (Diluted) | 73 | 74 | 75 | 76 | 76 | 76 | Upgrade |
Shares Change (YoY) | -1.91% | -2.13% | -0.66% | -0.66% | 0.66% | 0.53% | Upgrade |
EPS (Basic) | 6.72 | 6.75 | 7.98 | 7.87 | 8.89 | 4.68 | Upgrade |
EPS (Diluted) | 6.68 | 6.69 | 7.88 | 7.73 | 8.67 | 4.57 | Upgrade |
EPS Growth | -4.98% | -15.10% | 1.94% | -10.84% | 89.72% | 42.37% | Upgrade |
Free Cash Flow | 344 | 276.4 | 414.5 | 439.4 | 330.6 | 298.1 | Upgrade |
Free Cash Flow Growth | 24.46% | -33.32% | -5.67% | 32.91% | 10.90% | 23.80% | Upgrade |
Free Cash Flow Per Share | 4.71 | 3.75 | 5.50 | 5.80 | 4.33 | 3.93 | Upgrade |
Dividends Per Share | 0.830 | 0.810 | 0.770 | 0.730 | 0.690 | 0.650 | Upgrade |
Dividend Growth | 2.47% | 5.20% | 5.48% | 5.80% | 6.15% | 6.56% | Upgrade |
Gross Margin | 35.27% | 34.51% | 38.28% | 39.36% | 41.52% | 35.76% | Upgrade |
Operating Margin | 19.65% | 19.70% | 22.92% | 25.43% | 26.57% | 18.95% | Upgrade |
Profit Margin | 16.01% | 16.52% | 19.52% | 19.58% | 22.66% | 15.32% | Upgrade |
FCF Margin | 11.62% | 9.55% | 14.05% | 15.22% | 11.68% | 13.89% | Upgrade |
EBITDA | 743.9 | 725.3 | 813.3 | 854.6 | 874.6 | 516 | Upgrade |
EBITDA Margin | 25.13% | 25.07% | 27.57% | 29.60% | 30.89% | 24.03% | Upgrade |
EBIT | 581.6 | 569.9 | 676 | 734 | 752.3 | 406.9 | Upgrade |
EBIT Margin | 19.65% | 19.70% | 22.92% | 25.43% | 26.57% | 18.95% | Upgrade |
Effective Tax Rate | 20.68% | 18.36% | 17.52% | 16.87% | 14.31% | 18.07% | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.